News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-07 9:55:44 am CMMB Stock Earnings: Chemomab Therapeutics Reported Results for Q4 2023 InvestorPlace
2024-03-07 4:0:0 am Chemomab Therapeutics Announces Year End and Fourth Quarter 2023 Financial Results and Provides a Corporate Update PR Newswire
2024-03-05 4:0:0 am Chemomab Therapeutics to Participate in Leerink Global BioPharma Conference PR Newswire
2024-02-20 4:0:0 am Chemomab Awarded New Patents for CM-101, Its First-in Class Monoclonal Antibody in Clinical Development for Fibro-Inflammatory Diseases PR Newswire
2024-02-14 4:0:0 am Chemomab Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update PR Newswire
2024-02-05 4:0:0 am Chemomab Therapeutics to Participate in Upcoming Investor Conferences PR Newswire
2024-01-30 4:0:0 am Chemomab Therapeutics Announces New Publication Reinforcing the Clinical Potential of Its CCL24-Neutralizing Antibody CM-101 in Primary Sclerosing Cholangitis PR Newswire
2024-01-03 4:0:0 am Chemomab Announces Completion of Patient Enrollment in CM-101 Phase 2 Primary Sclerosing Cholangitis Trial and Moves Up Expected Topline Readout to Midyear 2024 PR Newswire
   

Please consider a small donation if you think this website provides you with relevant information